Mengchun Li

Mengchun Li, MD, MPA, is a Senior Director of Clinical Research in Infectious Disease at Merck since March 2023. Prior experience includes serving as a Therapeutic Area Manager and Study Responsible Physician at The Janssen Pharmaceutical Companies of Johnson & Johnson, overseeing clinical development projects, including phase III and IV trials, particularly in anti-fungal and anti-HIV products. Mengchun Li also worked as a Consultant Medical Monitor at the Global Alliance for TB Drug Development, focusing on tuberculosis clinical trials, and held a Director position in Pharmacovigilance, enhancing safety management processes. Mengchun Li earned a Master of Public Administration from Columbia University and an MD in Internal Medicine with a specialization in Endocrinology from China Medical University.